1. Executive Summary 2. United States Pediatric Vaccines Market Analysis, 2015 – 2019 and Forecast, 2020 – 2027 3. United States Pediatric Vaccines Market Share and Y–o–Y Growth (%) 4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market 4.1 Market Drivers 4.2 Market Inhibitors 5. United States Pediatric Vaccines Market – By Disease Indication (2015 – 2027) 5.1 Polio 5.1.1 Doses Administered (Volume) 5.1.2 Number of Children Being Vaccinated (Volume) 5.1.3 Market Size and Forecast (Value) 5.2 Hepatitis B 5.2.1 Doses Administered (Volume) 5.2.2 Number of Children Being Vaccinated (Volume) 5.2.3 Market Size and Forecast (Value) 5.3 Hepatitis A 5.3.1 Doses Administered (Volume) 5.3.2 Number of Children Being Vaccinated (Volume) 5.3.3 Market Size and Forecast (Value) 5.4 Diphtheria, Tetanus & Pertussis (DTaP) 5.4.1 Doses Administered (Volume) 5.4.2 Number of Children Being Vaccinated (Volume) 5.4.3 Market Size and Forecast (Value) 5.5 Haemophilus Influenzae Type B (HIB) 5.5.1 Doses Administered (Volume) 5.5.2 Number of Children Being Vaccinated (Volume) 5.5.3 Market Size and Forecast (Value) 5.6 Pneumococcal 5.6.1 Doses Administered (Volume) 5.6.2 Number of Children Being Vaccinated (Volume) 5.6.3 Market Size and Forecast (Value) 5.7 Measles, Mumps & Rubella (MMR) 5.7.1 Doses Administered (Volume) 5.7.2 Number of Children Being Vaccinated (Volume) 5.7.3 Market Size and Forecast (Value) 5.8 Varicella / Chicken Pox 5.8.1 Doses Administered (Volume) 5.8.2 Number of Children Being Vaccinated (Volume) 5.8.3 Market Size and Forecast (Value) 5.9 Rotavirus 5.9.1 Doses Administered (Volume) 5.9.2 Number of Children Being Vaccinated (Volume) 5.9.3 Market Size and Forecast (Value) 5.10 Influenza Pediatric 5.10.1 Doses Administered (Volume) 5.10.2 Number of Children Being Vaccinated (Volume) 5.10.3 Market Size and Forecast (Value) 6. Preventable Diseases and their Vaccines Available in the Market 7. United States Pediatric Vaccines Pricing Trends and Analysis 8. Regulatory Framework of the United States Pediatric Vaccines Market 9. Key Companies Analysis 9.1 Sanofi Pasteur 9.1.1 Business Overview 9.1.2 Pediatric Vaccines Portfolio 9.1.3 Recent Development 9.2 GlaxoSmithKline (GSK) 9.2.1 Business Overview 9.2.2 Pediatric Vaccines Portfolio 9.2.3 Recent Development 9.3 Merck 9.3.1 Business Overview 9.3.2 Pediatric Vaccines Portfolio 9.3.3 Recent Development 9.4 Pfizer 9.4.1 Business Overview 9.4.2 Pediatric Vaccines Portfolio 9.4.3 Recent Development 9.5 Grifols 9.5.1 Business Overview 9.5.2 Pediatric Vaccines Portfolio 9.5.3 Recent Development

List of Tables: Table 3–1: United States Pediatric Vaccines Market Share (Percent), 2015 – 2019 Table 3–2: United States Pediatric Vaccines Market Share Forecast (Percent), 2020 – 2027 Table 6–1: Preventable Diseases and their Vaccines Available in the Market Table 7–1: United States Pediatric Vaccines Price, 2020 – 2021 Table 8–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization List of Figures: Figure 2–1: United States Pediatric Vaccines Market (Million US$), 2015 – 2019 Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2020 – 2027 Figure 5–1: Polio Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–2: Polio Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–3: Number of Children Being Vaccinated with Polio Vaccines (in Million), 2015 – 2019 Figure 5–4: Number of Children Being Vaccinated with Polio Vaccines Forecast (in Million), 2020 –2027 Figure 5–5: Polio Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–6: Polio Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–7: Hepatitis B Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–8: Hepatitis B Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–9: Number of Children Being Vaccinated with Hepatitis B Vaccines (in Million), 2015 – 2019 Figure 5–10: Number of Children Being Vaccinated with Hepatitis B Vaccines Forecast (in Million), 2020 –2027 Figure 5–11: Hepatitis B Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–12: Hepatitis B Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–13: Hepatitis A Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–14: Hepatitis A Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–15: Number of Children Being Vaccinated with Hepatitis A Vaccines (in Million), 2015 – 2019 Figure 5–16: Number of Children Being Vaccinated with Hepatitis A Vaccines Forecast (in Million), 2020 –2027 Figure 5–17: Hepatitis A Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–18: Hepatitis A Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–19: DTaP Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–20: DTap Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–21: Number of Children Being Vaccinated with DTaP Vaccines (in Million), 2015 – 2019 Figure 5–22: Number of Children Being Vaccinated with DTaP Vaccines Forecast (in Million), 2020 –2027 Figure 5–23: DTaP Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–24: DTaP Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–25: HIB Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–26: HIB Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–27: Number of Children Being Vaccinated with HIB Vaccines (in Million), 2015 – 2019 Figure 5–28: Number of Children Being Vaccinated with HIB Vaccines Forecast (in Million), 2020 –2027 Figure 5–29: HIB Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–30: HIB Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–31: Pneumococcal Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–32: Pneumococcal Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–33: Number of Children Being Vaccinated with Pneumococcal Vaccines (in Million), 2015 – 2019 Figure 5–34: Number of Children Being Vaccinated with Pneumococcal Vaccines Forecast (in Million), 2020 –2027 Figure 5–35: Pneumococcal Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–36: Pneumococcal Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–37: MMR Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–38: MMR Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–39: Number of Children Being Vaccinated with MMR Vaccines (in Million), 2015 – 2019 Figure 5–40: Number of Children Being Vaccinated with MMR Vaccines Forecast (in Million), 2020 –2027 Figure 5–41: MMR Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–42: MMR Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–43: Varicella Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–44: Varicella Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–45: Number of Children Being Vaccinated with Varicella Vaccines (in Million), 2015 – 2019 Figure 5–46: Number of Children Being Vaccinated with Varicella Vaccines Forecast (in Million), 2020 –2027 Figure 5–47: Varicella Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–48: Varicella Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–49: Rotavirus Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–50: Rotavirus Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–51: Number of Children Being Vaccinated with Rotavirus Vaccines (in Million), 2015 – 2019 Figure 5–52: Number of Children Being Vaccinated with Rotavirus Vaccines Forecast (in Million), 2020 –2027 Figure 5–53: Rotavirus Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–54: Rotavirus Vaccines Market Value Forecast (in Million US$), 2020 – 2027 Figure 5–55: Influenza Pediatric Vaccines Doses Administered (in Million), 2015 – 2019 Figure 5–56: Influenza Pediatric Vaccines Doses Administered Forecast (in Million), 2020 – 2027 Figure 5–57: Number of Children Being Vaccinated with Influenza Pediatric Vaccines (in Million), 2015 – 2019 Figure 5–58: Number of Children Being Vaccinated with Influenza Pediatric Vaccines Forecast (in Million), 2020 –2027 Figure 5–59: Influenza Pediatric Vaccines Market Value (in Million US$), 2015 – 2019 Figure 5–60: Influenza Pediatric Vaccines Market Value Forecast (in Million US$), 2020 – 2027